Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Soars on MDS Acquisition

Shares of Molecular Devices closed up nearly 53 percent for the week ended Tuesday, following Monday’s announcement that MDS would acquire the firm for $35.50 per share (see related article). While Molecular Devices’ shares did not reach its 52-week high of $36.26, three other firms in the BCW Index did hit their 52-week high this past week. Qiagen closed up 4.22 percent at $16.78 for the tracking period, while Bio-Rad Laboratories climbed 2.8 percent to close at $85.15, and Becton Dickinson rose nearly 4 percent to close at $76.85.
 
Applied Biosystems, which last week posted second-quarter revenue growth of 10 percent (see related article), led decliners for the week, closing down 3.72 percent.
 
Overall, the Index rose 2.41 percent. In comparison, the Dow Jones Industrial Average fell .1 percent, the Nasdaq gained .7 percent, and the Nasdaq Biotech Index dropped .5 percent.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price (Jan. 30, 2007)
Starting Price Jan. (Jan. 23, 2007)
% change
Affymetrix
AFFX
24.89
24.7
0.77
Agilent
A
32
32.71
-2.17
Applied Biosystems
ABI
34.72
36.06
-3.72
Beckman
BEC
63.82
63.9
-0.13
Becton Dickinson
BDX
76.85
73.91
3.98
Bio-Rad
BIO
85.15
82.83
2.80
Bruker
BRKR
7.33
7.51
-2.40
Caliper
CALP
5.87
5.49
6.92
Cepheid
CPHD
8.43
8.25
2.18
Illumina
ILMN
39.5
40.98
-3.61
Invitrogen
IVGN
61.01
59.83
1.97
Luminex
LMNX
12.93
13.01
-0.61
Millipore
MIL
68.51
68.97
-0.67
Molecular Devices
MDCC
35.17
23.02
52.78
PerkinElmer
PKI
23.48
22.35
5.06
Qiagen
QGEN
16.78
16.1
4.22
Sequenom
SQNM
4.51
4.15
8.67
Sigma-Aldrich
SIAL
37.93
38.17
-0.63
Stratagene
STGN
7.33
7.07
3.68
Thermo
TMO
47.39
48.02
-1.31
Third Wave
TWTI
5
4.94
1.21
Waters
WAT
56.1
54.97
2.06
BCW Index Average
34.30
33.50
2.41
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.